Castleview Partners’s Milestone Scientific MLSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,750
Closed -$10.6K 714
2023
Q1
$10.6K Hold
11,750
0.01% 419
2022
Q4
$5.64K Hold
11,750
0.01% 436
2022
Q3
$9K Sell
11,750
-31,602
-73% -$30.7K 0.01% 397
2022
Q2
$150K Buy
43,352
+31,602
+269% +$32.2K 0.12% 168
2022
Q1
$17K Sell
11,750
-12,455
-51% -$18.2K 0.01% 448
2021
Q4
$11.8K Buy
+24,205
New +$53.2K 0.09% 83

Other funds holding MLSS

Castleview Partners's MLSS Position: Q2 2023 in Review

Castleview Partners sold out of Milestone Scientific (MLSS) in Q2 2023, closing a stake of 11,750 shares — an estimated $10.6K sold.

Castleview Partners first reported a position in MLSS in Q4 2021 and held it in 6 quarters. The position peaked at $150K in Q2 2022. 32 funds tracked by Wall St. Rank hold MLSS as of Q2 2023.

  • Castleview Partners reported no remaining Milestone Scientific position as of Q2 2023 after selling out during the quarter.
  • Castleview Partners sold 11,750 Milestone Scientific shares in Q2 2023, an estimated $10.6K.
  • Castleview Partners first reported a position in Milestone Scientific in Q4 2021 and held it in 6 quarters.
  • Castleview Partners's Milestone Scientific position peaked at $150K in Q2 2022.
  • 32 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2023.

Based on Castleview Partners's 13F filing for Q2 2023, filed 15 Aug 2023.